vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Elme Communities (ELME). Click either name above to swap in a different company.
Elme Communities is the larger business by last-quarter revenue ($62.1M vs $44.9M, roughly 1.4× AbCellera Biologics Inc.). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -198.9%, a 178.9% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 1.7%). Elme Communities produced more free cash flow last quarter ($7.2M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 2.7%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Elme Communities is a publicly traded U.S. real estate investment trust that primarily owns, operates and develops high-quality multifamily residential communities. It focuses on key growth markets across the U.S. Mid-Atlantic and Southeast, offering affordable to mid-tier housing options for diverse renter groups.
ABCL vs ELME — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $62.1M |
| Net Profit | $-8.9M | $-123.5M |
| Gross Margin | — | 61.1% |
| Operating Margin | -63.7% | -183.3% |
| Net Margin | -19.9% | -198.9% |
| Revenue YoY | 788.4% | 1.7% |
| Net Profit YoY | 73.9% | -4058.7% |
| EPS (diluted) | $-0.03 | $-1.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | — | ||
| Q3 25 | $9.0M | $62.1M | ||
| Q2 25 | $17.1M | $62.1M | ||
| Q1 25 | $4.2M | $61.5M | ||
| Q4 24 | $5.0M | $61.3M | ||
| Q3 24 | $6.5M | $61.1M | ||
| Q2 24 | $7.3M | $60.1M | ||
| Q1 24 | $10.0M | $59.5M |
| Q4 25 | $-8.9M | — | ||
| Q3 25 | $-57.1M | $-123.5M | ||
| Q2 25 | $-34.7M | $-3.6M | ||
| Q1 25 | $-45.6M | $-4.7M | ||
| Q4 24 | — | $-3.0M | ||
| Q3 24 | $-51.1M | $-3.0M | ||
| Q2 24 | $-36.9M | $-3.5M | ||
| Q1 24 | $-40.6M | $-3.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 61.1% | ||
| Q2 25 | — | 63.5% | ||
| Q1 25 | — | 64.2% | ||
| Q4 24 | — | 62.9% | ||
| Q3 24 | — | 63.5% | ||
| Q2 24 | — | 63.4% | ||
| Q1 24 | — | 63.5% |
| Q4 25 | -63.7% | — | ||
| Q3 25 | -851.8% | -183.3% | ||
| Q2 25 | -290.2% | 9.6% | ||
| Q1 25 | -1479.6% | 7.8% | ||
| Q4 24 | — | 10.4% | ||
| Q3 24 | -1439.4% | 11.0% | ||
| Q2 24 | -1276.2% | 9.8% | ||
| Q1 24 | -551.5% | 7.5% |
| Q4 25 | -19.9% | — | ||
| Q3 25 | -637.8% | -198.9% | ||
| Q2 25 | -203.3% | -5.7% | ||
| Q1 25 | -1077.2% | -7.6% | ||
| Q4 24 | — | -4.9% | ||
| Q3 24 | -785.4% | -4.9% | ||
| Q2 24 | -504.3% | -5.8% | ||
| Q1 24 | -408.0% | -6.1% |
| Q4 25 | $-0.03 | — | ||
| Q3 25 | $-0.19 | $-1.40 | ||
| Q2 25 | $-0.12 | $-0.04 | ||
| Q1 25 | $-0.15 | $-0.05 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | $-0.17 | $-0.03 | ||
| Q2 24 | $-0.13 | $-0.04 | ||
| Q1 24 | $-0.14 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $7.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $908.9M |
| Total Assets | $1.4B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | $7.1M | ||
| Q2 25 | $92.4M | $4.8M | ||
| Q1 25 | $159.3M | $6.4M | ||
| Q4 24 | $156.3M | $6.1M | ||
| Q3 24 | $126.6M | $4.8M | ||
| Q2 24 | $148.3M | $5.6M | ||
| Q1 24 | $123.6M | $4.2M |
| Q4 25 | $966.9M | — | ||
| Q3 25 | $964.0M | $908.9M | ||
| Q2 25 | $1.0B | $1.0B | ||
| Q1 25 | $1.0B | $1.1B | ||
| Q4 24 | $1.1B | $1.1B | ||
| Q3 24 | $1.1B | $1.1B | ||
| Q2 24 | $1.1B | $1.1B | ||
| Q1 24 | $1.1B | $1.1B |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.4B | $1.8B | ||
| Q1 25 | $1.3B | $1.8B | ||
| Q4 24 | $1.4B | $1.8B | ||
| Q3 24 | $1.4B | $1.9B | ||
| Q2 24 | $1.4B | $1.9B | ||
| Q1 24 | $1.5B | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $15.9M |
| Free Cash FlowOCF − Capex | $-44.6M | $7.2M |
| FCF MarginFCF / Revenue | -99.4% | 11.6% |
| Capex IntensityCapex / Revenue | 21.9% | 14.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $86.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | — | ||
| Q3 25 | $-52.6M | $15.9M | ||
| Q2 25 | $-32.4M | $29.8M | ||
| Q1 25 | $-11.6M | $16.2M | ||
| Q4 24 | $-108.6M | $95.2M | ||
| Q3 24 | $-28.9M | $20.7M | ||
| Q2 24 | $-30.0M | $28.9M | ||
| Q1 24 | $-41.7M | $21.2M |
| Q4 25 | $-44.6M | — | ||
| Q3 25 | $-61.5M | $7.2M | ||
| Q2 25 | $-45.8M | $21.1M | ||
| Q1 25 | $-22.2M | $10.5M | ||
| Q4 24 | $-187.0M | $47.9M | ||
| Q3 24 | $-47.4M | $8.8M | ||
| Q2 24 | $-50.1M | $21.0M | ||
| Q1 24 | $-65.8M | $7.6M |
| Q4 25 | -99.4% | — | ||
| Q3 25 | -687.0% | 11.6% | ||
| Q2 25 | -267.9% | 34.1% | ||
| Q1 25 | -524.0% | 17.1% | ||
| Q4 24 | -3702.8% | 78.1% | ||
| Q3 24 | -728.4% | 14.4% | ||
| Q2 24 | -683.8% | 34.9% | ||
| Q1 24 | -661.5% | 12.8% |
| Q4 25 | 21.9% | — | ||
| Q3 25 | 99.7% | 14.0% | ||
| Q2 25 | 78.2% | 14.0% | ||
| Q1 25 | 251.1% | 9.2% | ||
| Q4 24 | 1552.7% | 77.4% | ||
| Q3 24 | 284.6% | 19.4% | ||
| Q2 24 | 274.6% | 13.1% | ||
| Q1 24 | 242.5% | 22.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
ELME
| Residential Segment | $57.7M | 93% |
| Other | $4.4M | 7% |
